HAI Book 2025 - Flipbook - Page 96
Board 30
Board 31
Board 32
Board 33
of tau abnormality using
[18F]flortaucipir PET
Functional and structural
connectivity patterns predict
longitudinal tau spreading in
asymptomatic individuals
expressing A´ pathology
Plasma phospho-tau 217,
neurofilament-light, and glial
fibrillary acidic protein are
differentially associated with
longitudinal neuropsychiatric
symptoms across the early
cognitive spectrum
An assessment of the utility of
flortaucipir PET to detect fourrepeat tau pathology in a globular
glia tauopathy case-series
Molecular imaging of
neurodegeneration 3 mitochondria,
associated proteins and synapses
(MIND-MAPS) in frontotemporal
dementia
Pittsburgh School of Medicine,
Pittsburgh, PA, US
Gallego-Rudolf | Qiu | Javanray |
Wiesman | St-Onge | FajardoValdez | Baillet | Villeneuve
Jonathan Gallego-Rudolf,
Douglas Research Centre,
Montreal, QC, CA
Gatchel | Yu | Palmer | Wu | Beltran
| Munro | Webb | Blacker | Arnold |
Marshall | Dodge
Jennifer Gatchel,
Massachusetts General Hospital,
Department of Psychiatry,
Boston, MA, US
Gatto | Youssef | Ghatamaneni |
Uruk | Min | Fu | Reichard | Lowe |
Dickson | Whitwell | Josephs
Rodolfo Gatto, Department of
Neurology, Mayo Clinic,
Rochester, MN, US
Clarke | Whittington | Passchier |
Lewis | Passamonti | Chen |
Salinas | Tsukada | Cash | Rabiner |
Rohrer
Mica Clarke, Perceptive,
London, GB
Board 34
Evaluating tVNS effects on
cognitive outcomes and modulating
factors in asymptomatic older
adults: study design of the WALLe
Trial
Engels-Domínguez | Grube |
Fenlon | Wiklund | Heinrich |
Baillet | van Egroo | Papp |
Riphagen | Garcia | Sclocco |
Johnson | Napadow | Jacobs
Board 35
Cerebral perfusion indices from
early-phase [18F]-MK6240 dynamic
Tau PET imaging in brain regions
associated with Alzheimer9s Disease
progression in an aging population.
Dhaynaut | Lois | Tiss | Thibault |
Fanglu Fu | Ouyang | Johnson | El
Fakhri | Normandin | Guehl
Board 36
Transcutaneous auricular vagus
nerve stimulation improves learning
and sleep-wake quality in older
APOE-ε4 carriers
Baillet | Van Egroo | EngelsDomínguez | Grube | Fenlon |
Wiklund | Heinrich | Riphagen |
Papp | Garcia | Sclocco | Napadow
| Jacobs
Board 37
Biological-clinical mismatch
reflects co-pathology and
vulnerability to neurodegeneration
Brown | Das | Xie | Nasrallah | Detre
| Yushkevich | McMillan | Wolk
Board 38
Validation of PET spatial extent as
sensitive amyloid biomarker in early
stages of amyloidosis
Del Carmen Montenegro | Thibault
| Fanglu Fu | Price | Hanseeuw |
Jacobs | Sperling | Johnson |
Farrell
Board 41
Board 39
Developing a novel reference region
for PI-2620-PET imaging to
facilitate assessment of 4-repeat
tauopathies
P-TAU217, GFAP, and NFL plasma
biomarker associations with
demographic, medical and
neurocognitive features from
middle-aged through older
adulthood
Nina Engels-Domínguez, The
Athinoula A. Martinos Center for
Biomedical Imaging, Department
of Radiology, Massachusetts
General Hospital, Harvard
Medical School, Boston, MA, US
Maeva Dhaynaut, Yale PET
Center, Department of Radiology
& Biomedical Imaging, Yale
University School of Medicine,
New Haven, CT, US
Marion Baillet, Athinoula A.
Martinos Center for Biomedical
Imaging, Department of
Radiology, Massachusetts
General Hospital, Boston, MA, US
Christopher Brown, Department
of Neurology, University of
Pennyslvania, Philadelphia, PA,
US
Grace Del Carmen Montenegro,
Department of Radiology,
Massachusetts General Hospital,
Harvard Medical School, Boston,
MA, US
Frontzkowski
Lukas Frontzkowski, Institute
for Stroke and Dementia
Research (ISD), Munich, DE
Arnold | Kivisakk | Fatima |
Gentsch | Cruchaga | Wu | Dodge |
Ances | Salat
Steven Arnold, Massachusetts
General Hospital, Harvard
Medical School, Boston, MA, US
HAI2025 - 96
